Reference for Chapter 145: Merkel cell carcinoma

1 Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972;105(1):107–10. Cross Ref link Pubmed link
2 Rywlin AM. Malignant Merkel‐cell tumor is a more accurate description than trabecular carcinoma. Am J Dermatopathol 1982;4(6):513–15. Cross Ref link Pubmed link
3 Tilling T, Moll I. Which are the cells of origin in merkel cell carcinoma? J Skin Cancer 2012, doi: 10.1155/2012/680410. Pubmed link
4 Van Keymeulen A, Mascre G, Youseff KK, et al. Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol 2009;187(1):91–100. Cross Ref link Pubmed link
5 Zur Hausen A, Rennspiess D, Winnepenninckx V, Speel E‐JM, Kurz AK. Early B‐cell differentiation in Merkel cell carcinomas: clues to cellular ancestry. Cancer Res 2013;73(16):4982–7. Cross Ref link Pubmed link
6 Agelli M, Clegg LX, Becker JC, Rollison DE. The etiology and epidemiology of merkel cell carcinoma. Curr Probl Cancer 2010;34(1):14–37. Cross Ref link Pubmed link
7 Girschik J, Thorn K, Beer TW, Heenan PJ, Fritschi L. Merkel cell carcinoma in Western Australia: a population‐based study of incidence and survival. Br J Dermatol 2011;165(5):1051–7. Cross Ref link Pubmed link
8 Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population‐based study of 808 cases in 1993–2007. Eur J Cancer 2010;47(4):579–85. Cross Ref link Pubmed link
9 Kaae J, Hansen AV, Biggar RJ, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst 2010;102(11):793–801. Cross Ref link Pubmed link
10 Albores‐Saavedra J, Batich K, Chable‐Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010;37(1):20–7. Cross Ref link Pubmed link
11 O'Reilly F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management. J Am Dermatol 2011;65(2):253–61. Cross Ref link
12 Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant 2012;13(1):174–83. Cross Ref link Pubmed link
13 Koljonen V, Kukko H, Tukiainen E, et al. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study. Cancer Epidemiol 2010;34(1):62–5. Cross Ref link Pubmed link
14 Van Gele M, Boyle GM, Cook AL, et al. Gene‐expression profiling reveals distinct expression patterns for classic versus variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small‐cell lung carcinoma. Oncogene 2004;23(15):2732–42. Cross Ref link Pubmed link
15 Paulson KG, Iyer JG, Tegeder AR, et al. Transcriptome‐wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 2011;29(12):1539–46. Cross Ref link Pubmed link
16 Lunder EJ, Stern RS. Merkel‐cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998;339(17):1247–8. Cross Ref link Pubmed link
17 Triozzi P, Fernandez A. The role of the immune response in Merkel cell carcinoma. Cancers 2013;5(1):234–54. Cross Ref link Pubmed link
18 Wooff JC, Trites JR, Walsh NMG, Bullock MJ. Complete spontaneous regression of metastatic merkel cell carcinoma: a case report and review of the literature. Am J Dermatopathol 2010;32(6):614–17. Cross Ref link Pubmed link
19 Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319(5866):1096–100. Cross Ref link Pubmed link
20 Rollison DE, Giuliano AR, Becker JC. New virus associated with Merkel cell carcinoma development. J Natl Compr Cancer Network 2010;8(8):874–80.
21 Houben R, Shuda M, Weinkam R, et al. Merkel cell polyomavirus‐infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010;84(14):7064–72. Cross Ref link Pubmed link
22 Schrama D, Thiemann A, Houben R, Kähler KC, Becker JC, Hauschild A. Distinction of 2 different primary Merkel cell carcinomas in 1 patient by Merkel cell polyomavirus genome analysis. Arch Dermatol 2010;146(6):687–9. Cross Ref link Pubmed link
23 Shuda M, Feng H, Kwun HJ, et al. T antigen mutations are a human tumor‐specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci 2008;105(42):16272–7. Cross Ref link Pubmed link
24 Paulson KG, Carter JJ, Johnson LG, et al. Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients. Cancer Res 2010;70(21):8388–97. Cross Ref link Pubmed link
25 Lyngaa R, Pedersen NW, Schrama D, et al. Discovery of CD8 T cell epitopes in Merkel cell polyomavirus through combinatorial encoding with MHC multimers. J Immunother Cancer 2013;1(Suppl. 1):P13. Cross Ref link
26 Schwartz JL, Bichakjian CK, Lowe L, et al. Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort. Dermatol Surg 2013;39(7):1009–16. Cross Ref link Pubmed link
27 Sur M, AlArdati H, Ross C, Alowami S. TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis. Mod Pathol 2007;20(11):1113–20. Cross Ref link Pubmed link
28 Bastian BC, Kreipe HH, Bröcker EB. Primary neuroendocrine carcinoma of the skin with an unusual follicular lymphocytic infiltrate of the dermis. Am J Dermatopathol 1996;18(6):625–8. Cross Ref link Pubmed link
29 Becker JC, Assaf C, Vordermark D, et al. Brief S2k guidelines – Merkel cell carcinoma. J Dtsch Dermatol Ges 2013;11(Suppl. 3):29–36. Cross Ref link Pubmed link
30 Ferringer T, Rogers HC, Metcalf JS. Merkel cell carcinoma in situ. J Cutan Pathol 2005;32(2):162–5. Cross Ref link Pubmed link
31 Tarantola TI, Vallow LA, Halyard MY, et al. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol 2013;68(3):425–32. Cross Ref link Pubmed link
32 Zager JS, Rollison DE, Messina J. Prognostication in Merkel cell carcinoma. Expert Rev Anticancer Ther 2011;11(5):665–7. Cross Ref link Pubmed link
33 Lim CS, Whalley D, Haydu LE, et al. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma. Ann Surg Oncol 2012;19(11):3325–34. Cross Ref link Pubmed link
34 Schwartz JL, Griffith KA, Lowe L, et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol 2011;29(8):1036–41. Cross Ref link Pubmed link
35 Decaprio JA. Does detection of Merkel cell polyomavirus in Merkel cell carcinoma provide prognostic information? J Natl Cancer Inst 2009;101(13):905–7. Cross Ref link Pubmed link
36 Schrama D, Peitsch WK, Zapatka M, et al. Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. J Invest Dermatol 2011;131(8):1631–8. Cross Ref link Pubmed link
37 Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009;101(13):938–45. Cross Ref link Pubmed link
38 Becker JC, Kauczok CS, Ugurel S, Eib S, Bröcker E‐B, Houben R. Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy. J Dtsch Dermatol Ges 2008;6(9):709–19. Cross Ref link Pubmed link
39 Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58(3):375–81. Cross Ref link Pubmed link
40 Paulson KG, Iyer JG, Blom A, et al. systemic immune suppression predicts diminished Merkel cell carcinoma–specific survival independent of stage. J Invest Dermatol 2012;133(3):642–6. Cross Ref link Pubmed link
41 Colgan MB, Tarantola TI, Weaver AL, et al. The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma. J Am Dermatol 2012;67(6):1250–6. Cross Ref link
42 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Handbook – MCC. Berlin: Springer, 2009.
43 Lemos B, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010;63(5):751–61. Cross Ref link Pubmed link
44 Peloschek P, Novotny C, Mueller‐Mang C, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol 2010;73(2):317–23. Cross Ref link Pubmed link
45 Schmidt MC, Uhrhan K, Markiefka B, et al. (68)Ga‐DotaTATE PET‐CT followed by peptide receptor radiotherapy in combination with capecitabine in two patients with Merkel cell carcinoma. Int J Clin Exp Med 2012;5(4):363–6. Pubmed link
46 Siva S, Byrne K, Seel M, et al. 18F‐FDG PET provides high‐impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15‐year institutional experience. J Nucl Med 2013;54(8):1223–9. Cross Ref link Pubmed link
47 Ellis DL, Davis RS. Evidence‐based management of primary and localized Merkel cell carcinoma: a review. Int J Dermatol 2013;52(10):1248–58. Pubmed link
48 Tai P. A practical update of surgical management of merkel cell carcinoma of the skin. ISRN Surg 2013;2013(2):850797. Pubmed link
49 Foote M, Veness M, Zarate D, Poulsen M. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease. J Am Acad Dermatol 2012;67(3):395–9. Cross Ref link Pubmed link
50 Howle JR, Hughes TM, Gebski V, Veness MJ. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node‐negative patients. J Am Dermatol 2012;67(1):33–40. Cross Ref link
51 Stokes JB, Graw KS, Dengel LT, et al. Patients with Merkel cell carcinoma tumors. J Clin Oncol 2009;27(23):3772–7. Cross Ref link Pubmed link
52 Shnayder Y, Weed DT, Arnold DJ, et al. Management of the neck in Merkel cell carcinoma of the head and neck: University of Miami experience. Head Neck 2008;30(12):1559–65. Cross Ref link Pubmed link
53 Kaanders JH, Poortmans P, Zaucha R, et al. The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network. Radiat Oncol Biol 2011;81(4):e583–91. Cross Ref link
54 Kang SH, Haydu LE, Goh RYH, Fogarty GB. Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma. Radiat Oncol 2012;7:1–7. Cross Ref link Pubmed link
55 Veness MJ, Morgan GJ, Gebski V. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 2005;27(3):208–16. Cross Ref link Pubmed link
56 Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006;142(6):693–700. Pubmed link
57 Jouary T, Leyral C, Dreno B, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol 2012;23(4):1074–80. Cross Ref link Pubmed link
58 Hruby G, Scolyer RA, Thompson JF. The important role of radiation treatment in the management of Merkel cell carcinoma. Br J Dermatol 2013;169(5):975–82. Cross Ref link Pubmed link
59 Foote M, Harvey J, Porceddu S, et al. Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. Radiat Oncol Biol 2010;77(3):677–84. Cross Ref link
60 Fang LC, Lemos B, Douglas J, Iyer J, Nghiem P. Radiation monotherapy as regional treatment for lymph node‐positive Merkel cell carcinoma. Cancer 2010;116(7):1783–90. Cross Ref link Pubmed link
61 Veness M, Foote M, Gebski V, Poulsen M. The role of radiotherapy alone in patients with Merkel cell carcinoma: reporting the Australian experience of 43 patients. Radiat Oncol Biol 2010;78(3):703–9. Cross Ref link
62 Kumar A, Soares HP, Balducci L, Djulbegovic B, National Cancer Institute. Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute‐sponsored cooperative groups. J Clin Oncol 2007;25(10):1272–6. Cross Ref link Pubmed link
63 Henness S, Vereecken P. Management of Merkel tumours: an evidence‐based review. Curr Opin Oncol 2008;20(3):280–6. Cross Ref link Pubmed link
64 Becker JC. Merkel cell carcinoma. Ann Oncol 2010;21(Suppl. 7):vii81–5. Cross Ref link Pubmed link
65 Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000;18(12):2493–9. Pubmed link
66 Wobser M, Kürzinger N, Ugurel S, Bröcker E‐B, Becker JC. Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy. J Dtsch Dermatol Ges 2009;7(6):521–5. Pubmed link
67 Lipson EJ, Vincent JG, Loyo M, et al. PD‐L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival. Cancer Immunol Res 2013;1(1):54–63. Cross Ref link Pubmed link
68 Bhatia S, Afanasiev O, Nghiem P. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus‐associated cancer. Curr Oncol Rep 2011;13(6):488–97. Cross Ref link Pubmed link
69 Miller NJ, Bhatia S, Parvathaneni U, Iyer JG, Nghiem P. Emerging and mechanism‐based therapies for recurrent or metastatic Merkel cell carcinoma. Curr Treat Options Oncol 2013;14(2):249–63. Cross Ref link Pubmed link
70 Loader DE, Feldmann R, Baumgartner M, et al. Clinical remission of Merkel cell carcinoma after treatment with imatinib. J Am Dermatol 2013;69(4):e181–3. Cross Ref link
71 Samlowski WE, Moon J, Tuthill RJ, et al. A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group study (S0331). Am J Clin Oncol 2010;33(5):495–9. Cross Ref link Pubmed link
72 Davids MS, Davids M, Charlton A, et al. Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. J Clin Oncol 2009;27(26):e97–100. Cross Ref link Pubmed link
73 Hughes MP, Hardee ME, Cornelius LA, Hutchins LF, Becker JC, Gao L. Merkel cell carcinoma: epidemiology, target, and therapy. Curr Derm Rep 2014;22(3):46–53. Cross Ref link
74 Schrama D, Becker JC. Merkel cell carcinoma – pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2011;25(10):1121–9. Cross Ref link Pubmed link
75 Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007;110(1):1–12. Cross Ref link Pubmed link
76 Epstude M, Tornquist K, Riklin C, et al. Comparison of (18)F‐FDG PET/CT and (68)Ga‐DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma. Clin Nucl Med 2013;38(4):283–4. Cross Ref link Pubmed link

Log in to Rooks online